U.S. market Closed. Opens in 17 hours 6 minutes

ZJYL | Jin Medical International Ltd. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ZJYL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is moderate, Growth is bad and Health is passable.

Valuation (9%)

Company Industry
P/E Ratio (TTM) 91.14 52.02
PEG Ratio (TTM) 105.88 3.81
P/S Ratio (TTM) 13.17 12.48
P/B Ratio (TTM) 15.14 6.63
P/FCF Ratio (TTM) -631.58 331.58
Price to 5YR AVG Earnings Ratio N/A 115.37
Price to 5YR AVG FCF Ratio N/A 87.71

Profitability (55%)

Company Industry
ROA (TTM) 10.59% 6.95%
ROE (TTM) 17.36% 12.91%
Net Profit Margin (TTM) 14.44% 2.69%
ROIC 5YR AVG N/A 11.07%

Growth (43%)

4QTR AVG 3YR AVG 5YR AVG
EPS 20.21% -6.08% N/A
Revenue 25.46% 0.05% N/A
Net Income 28.04% -5.79% N/A
Cash Flow 15.03% 116.45% N/A

Health (60%)

Company Industry
Current Ratio (TTM) 2.58 3.38
Quick Ratio (TTM) 2.15 2.56
D/E Ratio (TTM) 0.38 0.39
Interest Coverage (TTM) N/A 27.94
Piotroski F-Score 6 6
Altman Z-Score 18.35 23.15
LTL to 5YR AVG FCF N/A 4.39
Shares Outstanding Growth 5YR AVG N/A 2.69%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙